Study evaluates the single-dose intranasal spray vaccine dNS1-RBD, finding it effective against symptomatic COVID-19, particularly in reducing severe symptoms and respiratory issues.
Intranasal COVID-19 vaccine shows promise in reducing severe symptoms
- Post author:
- Post published:December 14, 2023
- Post category:uncategorized